G1 Therapeutics and Simcere Announce Exclusive License Agreement for Trilaciclib in Greater China Read more
AbCellera Provides COVID-19 Program Update with the Start of Phase 3 Clinical Trials and the Expansion of its COVID-19 Antibody Database Read more
Innovent Announces First Patient Dosed in the Phase 1 Clinical Trial of Anti-CD47/PD-L1 Bispecific Antibody in China Read more